Table 4.
Crystallized GASPIDs
| GASPID | References | Special Features |
|---|---|---|
| Rat mast cell protease II + inhibitor | [79, 80] | Deep, extended substrate binding pocket |
| Human chymase + inhibitor | [81, 82] | High density of surface charge explains high affinity for proteoglycan |
| Human pro-chymase | [28] | Changes in active site conformation explain inactivity of pro-enzyme |
| Human cathepsin G + inhibitor | [86] | Active site mutations explain unusually broad specificity |
| Human β-tryptase + inhibitor | [54] | Toroidal, self-compartmentalizing tetramer; structure explains heparin stabilization |
| Human α-tryptase | [19] | Tetramer, with contorted, self-blocked active site |
| Human neutrophil elastase + inhibitor | [85] | Asymmetry of charge distribution explains proteoglycan binding |
| Rat Granzyme B + inhibitor | [87] | Structure explains unusual Asp specificity |
| Human Granzyme B | [142] | Structure explains unusual Asp specificity |
| Human granzyme A + inhibitor | [56, 57] | Dimer extends & protects active site |
| Human pro-granzyme K | [88] | Rigid, non-productive active site |
| Human Factor D | [52, 53] | Auto-blocked active site |